News
Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings dec ...
Served on Celgene's Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key ...
Triptans are contraindicated in patients with cardiovascular diseases and hypertension. Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO) inhibitors or within 2 ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and re ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...
Sumatriptan – Imitrex® 25, 50, 100 mg tablets 5, 20 mg nasal spray, 4, 6 mg/0.5 ml cartridges; 6 mg/0.5 ml vials 50 or 100 mg p.o.; can be repeated after 2 h (max 200 mg/day), 5, 10 or 20 mg ...
According to a 2020 review of studies, one study found evidence that ginger had similar efficacy to the migraine medication sumatriptan with a better side effect profile. More research is needed ...
If you can, avoid ES at all costs. My new 2025 insurance requires me to use them. Even if I don’t actually get things filled through them, they’re my overall PBM. I have had to go more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results